Brazil · Veterinary startup

InPulse Animal Health

InPulse Animal Health is a Brazilian veterinary technology company founded in 2011 and headquartered in Florianópolis, Santa Catarina.

Funding reportedLast round: Seed

VeterinaryFlorianopolis, Brazil

About InPulse Animal Health

InPulse Animal Health is a Brazilian veterinary technology company founded in 2011 and headquartered in Florianópolis, Santa Catarina.

The company focuses on developing advanced biomedical solutions for animal diagnosis and treatment, particularly in cardiology and wearable or implantable medical devices. InPulse operates across all states of Brazil, aiming to enhance animal health through innovative technology. The company offers a range of specialized veterinary equipment, including the INmonitor, a multiparametric monitor that provides physiological monitoring, ECG, and blood pressure measurement. They also provide the BP Scan mobile app for veterinary blood pressure monitoring and other high-precision devices tailored for feline health. InPulse supports veterinary professionals with telemedicine capabilities and educational initiatives, helping them deliver improved care to their patients.

What company datasets say InPulse Animal Health raised

Funding, as reported

Reported in all105kin the source's currency
Last roundSeed
Last round size80k
Last round dateJul 2013

The company, in detail

What they build

Known for

cardiologyveterinary serviceshospital & health caremedicalhealthcare itmedical devicesimplantable deviceswearable devicesveterinary

Built with from their website

Google Tag ManagerHREF LangCloudFlareViewport MetaFacebook SDKCloudFlare CDNPriority HintsCloudflare InsightsMobile FriendlyWhatsApp

+8 more

MultilingualBlue Host DNSOpen GraphFacebook PixelSnowplowMicrosoft ClarityDudaBlue Host

Sector
Veterinary
Industry code
NAICS 334510, 541940, SIC 3841, 0742
Region
State of Santa Catarina

Veterinary in Brazil

Startups like it

Is this your company?

Add your raise, your deck and your story, and put InPulse Animal Health in front of investors. Or tell us what we have wrong.